Bupivacaine versus lidocaine analgesia for neonatal circumcision

Orit C. Stolik-Dollberg, Shaul Dollberg

Research output: Contribution to journalArticlepeer-review


Background: Analgesia for neonatal circumcision was recently advocated for every male infant, and its use is considered essential by the American Academy of Pediatrics. We compared the post-operative analgesic quality of bupivacaine to that of lidocaine for achieving dorsal penile nerve block (DPNB) when performing neonatal circumcision. Methods: Data were obtained from 38 neonates following neonatal circumcision. The infants had received DPNB analgesia with either lidocaine or bupivacaine. The outcome variable was the administration by the parents of acetaminophen during the ensuing 24 hours. Results: Seventeen infants received lidocaine and 19 received bupivacaine DPNB. Ten infants in the lidocaine group (59%) were given acetaminophen following circumcision compared to only 3 (16%) in the bupivacaine group (P<0.01). Regression analysis showed that the only significant variable associated with the need for acetaminophen was the use of lidocaine (R2=20.6; P=0.006). Conclusion: DPNB with bupivacaine for neonatal circumcision apparently confers better analgesia than lidocaine as judged by the requirement of acetaminophen over the ensuing 24-hour period.

Original languageEnglish
Article number12
JournalBMC Pediatrics
StatePublished - 22 May 2005


  • Dorsal penile nerve block
  • EMLA cream
  • Long-term effects
  • Post-operative pain


Dive into the research topics of 'Bupivacaine versus lidocaine analgesia for neonatal circumcision'. Together they form a unique fingerprint.

Cite this